Bioreactors Market Size By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column), By End-Use (R&D Organizations, Biopharma Manufacturers, CMOs), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, The Netherlands, Denmark, China, Japan, India Australia, South Korea, Singapore, Brazil, Mexico, South Africa, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

Choose Licence

 

Bioreactors Market will exceed USD 2.2 billion by 2025; as per a new research report. Growing biopharmaceutical and biologics industry and technological advancements in bioreactors, coupled with growing demand for orphan drugs and personalized medicines are the major driving factors for the global bioreactors market growth during the forecast period. The growth of biopharmaceutical industry can be attributed to the rising prevalence of chronic disease, increasing aging population, and increased investment in technological advances; especially in the personalized and targeted therapies. Moreover, biological drugs are more effective in comparison to traditional treatments leading to their increasing popularity. Growing biopharmaceutical industry and use of bioreactors for large-scale production of biopharmaceutical products have generated the need for suppliers to provide excellent product quality, strong change management, and assurance of supply coupled with business continuity. The bioreactor manufacturers strive to develop quality designs and seek consistent performance by partnering with material and component suppliers as well as research scientists for technical know-how. The reliability of the value chain for bioreactors depends upon partnerships and agreements with suppliers and complete understanding and control of the bioreactor manufacturing process. Mammalian cells segment accounted for more than 75% market share in 2018 owing to its wide application in production of therapeutic proteins and viral vaccines. Other cells should witness more than 13.0% growth over the forecast timeframe due to associated benefits of insect cells such as ease of culture, by-product concentration, high tolerance to osmolality, and higher expression levels. Monoclonal antibodies generated over USD 270.0 million in 2018 owing to its increasing application in treatment of asthma, breast cancers, rheumatoid arthritis, psoriasis, leukemia, chronic gastrointestinal inflammatory disease, and transplant rejection. Other molecules will grow at more than 16.0% with expectations to surpass USD 200.0 million by 2025. Oligonucleotides demand should increase with the growing research in molecular diagnostics field and soaring investments in genomic technologies. Wave-induced motion market held more than 50% of industry revenue in 2018 due to its extensive use in modern biotechnological processes. Stirred SUBs will witness more than 17.0% CAGR owing to its huge demand in the biopharmaceutical industry. The ability to reduce scale-up risks and maintain clean environment throughout the production process should stimulate industry growth. Europe dominated the global bioreactors market and was valued at around USD 284.0 million in the year 2018 owing to the presence of leading industry players and increasing healthcare expenditure in this region. Favorable regulatory policies for biopharmaceutical approval and technological innovation in bioprocess equipment will propel business growth. The major industry players in the bioreactors market are Sartorius, GE Healthcare, Thermo Fisher Scientific, Eppendorf, and Merck Millipore. Major strategies adopted by the players in the market include new product launch, acquisition strategy, expansion strategy, agreements, and collaborations, among others. For instance, In June 2016, Sartorius acquired Intellicyt, a firm specialized in cell screening. This acquisition expanded Sartorious’ product lab portfolio and strengthened its offering for biopharma customers and helped in penetrating the market.

 

Report Content Chapter 1. Methodology 1.1. Methodology 1.1.1. Initial data exploration 1.1.2. Statistical model and forecast 1.1.3. Industry insights and validation 1.1.4. Market definition and forecast parameters 1.2. Data sources 1.2.1. Secondary 1.2.2. Primary Chapter 2. Executive Summary 2.1. Bioreactors industry 360 degree synopsis, 2014 - 2025 2.1.1. Business trends 2.1.2. Cell trends 2.1.3. Molecule trends 2.1.4. Technology trends 2.1.5. End-use trends 2.1.6. Regional trends Chapter 3. Bioreactors Industry Insights 3.1. Industry segmentation 3.2. Industry landscape, 2014 - 2025 3.3. Industry ecosystem analysis 3.3.1. Distribution channel analysis 3.3.2. Vendor matrix 3.4. Regulatory Landscape 3.4.1. U.S. 3.4.2. Canada 3.4.3. Germany 3.4.4. UK 3.4.5. China 3.5. Industry impact forces 3.5.1. Growth drivers 3.5.1.1. Growing biopharmaceuticals and biologics industry 3.5.1.2. Technological advancements in bioreactors 3.5.1.3. Growing orphan drugs developments 3.5.1.4. Increasing demand for personalized medicines 3.5.2. Industry pitfalls & challenges 3.5.2.1. Low capacity of single-use bioreactor 3.5.2.2. Concerns regarding extractables and/or leachables 3.6. Growth potential analysis 3.6.1. By cell 3.6.2. By molecule 3.6.3. By technology 3.6.4. By end-use 3.7. Outsourcing landscape 3.8. Technology landscape 3.8.1. U.S. 3.8.2. Europe 3.9. Porter's analysis 3.10. Competitive landscape, 2017 3.10.1. Strategy dashboard 3.11. PESTEL analysis Chapter 4. Bioreactors Market, by Cell 4.1. Key segment trends 4.2. Mammalian cells 4.2.1. Market estimates and forecast, by region, 2014 - 2025 4.3. Bacterial cells 4.3.1. Market estimates and forecast, by region, 2014 - 2025 4.4. Yeast cells 4.4.1. Market estimates and forecast, by region, 2014 - 2025 4.5. Others 4.5.1. Market estimates and forecast, by region, 2014 - 2025 Chapter 5. Bioreactors Market, By Molecule 5.1. Key segment trends 5.2. Monoclonal antibodies 5.2.1. Market estimates and forecast, by region, 2014 - 2025 5.3. Vaccines 5.3.1. Market estimates and forecast, by region, 2014 - 2025 5.4. Recombinant protein 5.4.1. Market estimates and forecast, by region, 2014 - 2025 5.5. Stem cell 5.5.1. Market estimates and forecast, by region, 2014 - 2025 5.6. Gene therapy 5.6.1. Market estimates and forecast, by region, 2014 - 2025 5.7. Others 5.7.1. Market estimates and forecast, by region, 2014 - 2025 Chapter 6. Bioreactors Market, By Technology 6.1. Key segment trends 6.2. Wave-induced motion SUB 6.2.1. Market estimates and forecast, by region, 2014 - 2025 6.3. Stirred SUB 6.3.1. Market estimates and forecast, by region, 2014 - 2025 6.4. Stirred-use bubble column 6.4.1. Market estimates and forecast, by region, 2014 - 2025 6.5. Others 6.5.1. Market estimates and forecast, by region, 2014 - 2025 Chapter 7. Bioreactors Market, By End-use 7.1. Key segment trends 7.2. Research and development (R&D) organizations 7.2.1. Market estimates and forecast, by region, 2014 - 2025 7.3. Biopharma manufacturers 7.3.1. Market estimates and forecast, by region, 2014 - 2025 7.4. Contract manufacturing organisations (CMOs) 7.4.1. Market estimates and forecast, by region, 2014 - 2025 Chapter 8. Bioreactors Market, By Region 8.1. Key regional trends 8.2. North America 8.2.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million & Units) 8.2.2. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.2.3. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.2.4. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.2.5. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.2.6. U.S. 8.2.6.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.2.6.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.2.6.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.2.6.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.2.7. Canada 8.2.7.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.2.7.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.2.7.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.2.7.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.3. Europe 8.3.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million & Units) 8.3.2. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.3.3. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.3.4. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.3.5. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.3.6. Germany 8.3.6.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.3.6.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.3.6.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.3.6.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.3.7. UK 8.3.7.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.3.7.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.3.7.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.3.7.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.3.8. Spain 8.3.8.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.3.8.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.3.8.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.3.8.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.3.9. Italy 8.3.9.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.3.9.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.3.9.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.3.9.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.3.10. France 8.3.10.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.3.10.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.3.10.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.3.10.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.3.11. The Netherlands 8.3.11.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.3.11.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.3.11.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.3.11.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.3.12. Denmark 8.3.12.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.3.12.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.3.12.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.3.12.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.4. Asia Pacific 8.4.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million & Units) 8.4.2. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.4.3. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.4.4. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.4.5. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.4.6. China 8.4.6.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.4.6.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.4.6.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.4.6.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.4.7. Japan 8.4.7.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.4.7.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.4.7.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.4.7.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.4.8. India 8.4.8.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.4.8.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.4.8.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.4.8.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.4.9. South Korea 8.4.9.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.4.9.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.4.9.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.4.9.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.4.10. Australia 8.4.10.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.4.10.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.4.10.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.4.10.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.4.11. Singapore 8.4.11.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.4.11.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.4.11.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.4.11.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.5. Latin America 8.5.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million & Units) 8.5.2. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.5.3. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.5.4. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.5.5. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.5.6. Brazil 8.5.6.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.5.6.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.5.6.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.5.6.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.5.7. Mexico 8.5.7.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.5.7.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.5.7.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.5.7.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.6. Middle East & Africa 8.6.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million & Units) 8.6.2. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.6.3. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.6.4. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.6.5. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.6.6. South Africa 8.6.6.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.6.6.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.6.6.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.6.6.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) 8.6.7. UAE 8.6.7.1. Market estimates and forecast, by cell, 2014 - 2025 (USD Million) 8.6.7.2. Market estimates and forecast, by molecule, 2014 - 2025 (USD Million) 8.6.7.3. Market estimates and forecast, by technology, 2014 - 2025 (USD Million & Units) 8.6.7.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million & Units) Chapter 9. Company Profiles 9.1. Thermo Fisher Scientific 9.1.1. Business overview 9.1.2. Financial data 9.1.3. Product landscape 9.1.4. Strategic outlook 9.1.5. SWOT analysis 9.2. PBS Biotech 9.2.1. Business overview 9.2.2. Financial data 9.2.3. Product landscape 9.2.4. Strategic outlook 9.2.5. SWOT analysis 9.3. GE Healthcare 9.3.1. Business overview 9.3.2. Financial data 9.3.3. Product landscape 9.3.4. Strategic outlook 9.3.5. SWOT analysis 9.4. Merck Group 9.4.1. Business overview 9.4.2. Financial data 9.4.3. Product landscape 9.4.4. Strategic outlook 9.4.5. SWOT analysis 9.5. Cellexus Ltd 9.5.1. Business overview 9.5.2. Financial data 9.5.3. Product landscape 9.5.4. Strategic outlook 9.5.5. SWOT analysis 9.6. Pall Corporation 9.6.1. Business overview 9.6.2. Financial data 9.6.3. Product landscape 9.6.4. Strategic outlook 9.6.5. SWOT analysis 9.7. Sartorius Stedim Biotech Group 9.7.1. Business overview 9.7.2. Financial data 9.7.3. Product landscape 9.7.4. Strategic outlook 9.7.5. SWOT analysis 9.8. Applikon Biotechnology, Inc. 9.8.1. Business overview 9.8.2. Financial data 9.8.3. Product landscape 9.8.4. Strategic outlook 9.8.5. SWOT analysis 9.9. GEA Group Aktiengesellschaft 9.9.1. Business overview 9.9.2. Financial data 9.9.3. Product landscape 9.9.4. Strategic outlook 9.9.5. SWOT analysis 9.10. BioTron, Inc. 9.10.1. Business overview 9.10.2. Financial data 9.10.3. Product landscape 9.10.4. Strategic outlook 9.10.5. SWOT analysis 9.11. Bbi Biotech 9.11.1. Business overview 9.11.2. Financial data 9.11.3. Product landscape 9.11.4. Strategic outlook 9.11.5. SWOT analysis 9.12. Shanghai Bailun Biotechnology Co., Ltd. 9.12.1. Business overview 9.12.2. Financial data 9.12.3. Product landscape 9.12.4. Strategic outlook 9.12.5. SWOT analysis 9.13. CerCell Aps 9.13.1. Business overview 9.13.2. Financial data 9.13.3. Product landscape 9.13.4. Strategic outlook 9.13.5. SWOT analysis 9.14. Eppendorf AG 9.14.1. Business overview 9.14.2. Financial data 9.14.3. Product landscape 9.14.4. Strategic outlook 9.14.5. SWOT analysis 9.15. Solaris Biotech Solutions 9.15.1. Business overview 9.15.2. Financial data 9.15.3. Product landscape 9.15.4. Strategic outlook 9.15.5. SWOT analysis 9.16. Pierre Guérin 9.16.1. Business overview 9.16.2. Financial data 9.16.3. Product landscape 9.16.4. Strategic outlook 9.16.5. SWOT analysis 9.17. CESCO Bioengineering Co. Ltd. 9.17.1. Business overview 9.17.2. Financial data 9.17.3. Product landscape 9.17.4. Strategic outlook 9.17.5. SWOT analysis

Data Tables TABLE 1 Bioreactors industry 360 degree synopsis, 2014 - 2025 TABLE 2 Global bioreactors market, 2014 - 2025 (USD Million) TABLE 3 Global bioreactors market, by cell type, 2014 - 2025 (USD Million) TABLE 4 Global bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 5 Global bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 6 Global bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 7 Global bioreactors market, by region, 2014 - 2025 (USD Million) TABLE 8 Industry impact forces TABLE 9 Mammalian cells market size, by region, 2014 - 2025 (USD Million) TABLE 10 Bacterial cells market size, by region, 2014 - 2025 (USD Million) TABLE 11 Yeast cells market size, by region, 2014 - 2025 (USD Million) TABLE 12 Others market size, by region, 2014 - 2025 (USD Million) TABLE 13 Monoclonal antibodies size, by region, 2014 - 2025 (USD Million) TABLE 14 Vaccine market size, by region, 2014 - 2025 (USD Million) TABLE 15 Recombinant protein market size, by region, 2014 - 2025 (USD Million) TABLE 16 Stem cell market size, by region, 2014 - 2025 (USD Million) TABLE 17 Gene therapy market size, by region, 2014 - 2025 (USD Million) TABLE 18 Others market size, by region, 2014 - 2025 (USD Million) TABLE 19 Wave-induced motion SUB market size, by region, 2014 - 2025 (USD Million) TABLE 20 Wave-induced motion SUB market size, by region, 2014 - 2025 (Units) TABLE 21 Stirred SUB market size, by region, 2014 - 2025 (USD Million) TABLE 22 Stirred SUB market size, by region, 2014 - 2025 (Units) TABLE 23 Single-use bubble column market size, by region, 2014 - 2025 (USD Million) TABLE 24 Single-use bubble column market size, by region, 2014 - 2025 (Units) TABLE 25 Others market size, by region, 2014 - 2025 (USD Million) TABLE 26 Others market size, by region, 2014 - 2025 (Units) TABLE 27 Research and development market size, by region, 2014 - 2025 (USD Million) TABLE 28 Research and development market size, by region, 2014 - 2025 (Units) TABLE 29 Biopharma manufacturers market size, by region, 2014 - 2025 (USD Million) TABLE 30 Biopharma manufacturers market size, by region, 2014 - 2025 (Units) TABLE 31 Contract manufacturing organisations market size, by region, 2014 - 2025 (USD Million) TABLE 32 Contract manufacturing organisations market size, by region, 2014 - 2025 (Units) TABLE 33 North America bioreactors market size, by country, 2014 - 2025 (USD Million) TABLE 34 North America bioreactors market size, by country, 2014 - 2025 (Units) TABLE 35 North America bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 36 North America bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 37 North America bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 38 North America bioreactors market, by technology, 2014 - 2025 (Units) TABLE 39 North America bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 40 North America bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 41 U.S. bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 42 U.S. bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 43 U.S. bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 44 U.S. bioreactors market, by technology, 2014 - 2025 (Units) TABLE 45 U.S. bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 46 U.S. bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 47 Canada bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 48 Canada bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 49 Canada bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 50 Canada bioreactors market, by technology, 2014 - 2025 (Units) TABLE 51 Canada bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 52 Canada bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 53 Europe bioreactors market size, by country, 2014 - 2025 (USD Million) TABLE 54 Europe bioreactors market size, by country, 2014 - 2025 (Units) TABLE 55 Europe bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 56 Europe bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 57 Europe bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 58 Europe bioreactors market, by technology, 2014 - 2025 (Units) TABLE 59 Europe bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 60 Europe bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 61 Germany bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 62 Germany bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 63 Germany bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 64 Germany bioreactors market, by technology, 2014 - 2025 (Units) TABLE 65 Germany bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 66 Germany bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 67 UK bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 68 UK bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 69 UK bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 70 UK bioreactors market, by technology, 2014 - 2025 (Units) TABLE 71 UK bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 72 UK bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 73 Spain bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 74 Spain bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 75 Spain bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 76 Spain bioreactors market, by technology, 2014 - 2025 (Units) TABLE 77 Spain bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 78 Spain bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 79 Italy bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 80 Italy bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 81 Italy bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 82 Italy bioreactors market, by technology, 2014 - 2025 (Units) TABLE 83 Italy bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 84 Italy bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 85 France bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 86 France bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 87 France bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 88 France bioreactors market, by technology, 2014 - 2025 (Units) TABLE 89 France bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 90 France bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 91 The Netherlands bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 92 The Netherlands bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 93 The Netherlands bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 94 The Netherlands bioreactors market, by technology, 2014 - 2025 (Units) TABLE 95 The Netherlands bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 96 The Netherlands bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 97 Denmark bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 98 Denmark bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 99 Denmark bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 100 Denmark bioreactors market, by technology, 2014 - 2025 (Units) TABLE 101 Denmark bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 102 Denmark bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 103 Asia Pacific bioreactors market size, by country, 2014 - 2025 (USD Million) TABLE 104 Europe bioreactors market size, by country, 2014 - 2025 (Units) TABLE 105 Asia Pacific bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 106 Asia Pacific bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 107 Asia Pacific bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 108 Asia Pacific bioreactors market, by technology, 2014 - 2025 (Units) TABLE 109 Asia Pacific bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 110 Asia Pacific bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 111 China bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 112 China bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 113 China bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 114 China bioreactors market, by technology, 2014 - 2025 (Units) TABLE 115 China bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 116 China bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 117 Japan bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 118 Japan bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 119 Japan bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 120 Japan bioreactors market, by technology, 2014 - 2025 (Units) TABLE 121 Japan bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 122 Japan bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 123 India bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 124 India bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 125 India bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 126 India bioreactors market, by technology, 2014 - 2025 (Units) TABLE 127 India bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 128 India bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 129 South Korea bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 130 South Korea bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 131 South Korea bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 132 South Korea bioreactors market, by technology, 2014 - 2025 (Units) TABLE 133 South Korea bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 134 South Korea bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 135 Australia bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 136 Australia bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 137 Australia bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 138 Australia bioreactors market, by technology, 2014 - 2025 (Units) TABLE 139 Australia bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 140 Australia bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 141 Singapore bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 142 Singapore bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 143 Singapore bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 144 Singapore bioreactors market, by technology, 2014 - 2025 (Units) TABLE 145 Singapore bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 146 Singapore bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 147 Latin America bioreactors market size, by country, 2014 - 2025 (USD Million) TABLE 148 Latin America bioreactors market size, by country, 2014 - 2025 (Units) TABLE 149 Latin America bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 150 Latin America bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 151 Latin America bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 152 Latin America bioreactors market, by technology, 2014 - 2025 (Units) TABLE 153 Latin America bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 154 Latin America bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 155 Brazil bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 156 Brazil bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 157 Brazil bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 158 Brazil bioreactors market, by technology, 2014 - 2025 (Units) TABLE 159 Brazil bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 160 Brazil bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 161 Mexico bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 162 Mexico bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 163 Mexico bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 164 Mexico bioreactors market, by technology, 2014 - 2025 (Units) TABLE 165 Mexico bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 166 Mexico bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 167 MEA bioreactors market size, by country, 2014 - 2025 (USD Million) TABLE 168 MEA bioreactors market size, by country, 2014 - 2025 (Units) TABLE 169 MEA bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 170 MEA bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 171 MEA bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 172 MEA bioreactors market, by technology, 2014 - 2025 (Units) TABLE 173 MEA bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 174 MEA bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 175 UAE bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 176 UAE bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 177 UAE bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 178 UAE bioreactors market, by technology, 2014 - 2025 (Units) TABLE 179 UAE bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 180 UAE bioreactors market, by end-use, 2014 - 2025 (Units) TABLE 181 South Africa bioreactors market, by cell, 2014 - 2025 (USD Million) TABLE 182 South Africa bioreactors market, by molecule, 2014 - 2025 (USD Million) TABLE 183 South Africa bioreactors market, by technology, 2014 - 2025 (USD Million) TABLE 184 South Africa bioreactors market, by technology, 2014 - 2025 (Units) TABLE 185 South Africa bioreactors market, by end-use, 2014 - 2025 (USD Million) TABLE 186 South Africa bioreactors market, by end-use, 2014 - 2025 (Units) Charts & Figures FIG. 1 Industry segmentation FIG. 2 Global bioreactors market, 2014 - 2025 (USD Million) FIG. 3 Industry ecosystem analysis FIG. 4 Distribution channel analysis FIG. 5 Vendor matrix FIG. 6 Growth potential analysis, by cell FIG. 7 Growth potential analysis, by molecule FIG. 8 Growth potential analysis, by technology FIG. 9 Growth potential analysis, by end-use FIG. 10 Outsourcing landscape FIG. 11 Technological landscape FIG. 12 Porter's analysis FIG. 13 Competitive landscape, 2014 - 2017 FIG. 14 Strategic dashboard FIG. 15 PESTEL analysis


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by Global Market Insights, Inc.

New Pharmaceuticals and Healthcare Reports